#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The impact of delivery mode on epigenetic changes in newborns and their health outcomes


Vplyv spôsobu pôrodu na epigenetické zmeny u novorodencov a ich zdravotné následky

V posledných desaťročiach sme zaznamenali výrazný nárast počtu cisárskych rezov. Hoci je pôrod cisárskym rezom život zachraňujúci, je spojený so zvýšeným rizikom nepriaznivých zdravotných následkov u novorodencov, vrátane respiračných a atopických ochorení, obezity, cukrovky a závažných autoimunitných ochorení. Presné mechanizmy, ktoré sú základom týchto spojitostí zostávajú nepochopené; epigenetické modifikácie sa však ukázali ako pravdepodobný molekulárny základ spájajúci perinatálne faktory s budúcou náchylnosťou na ochorenie. Tento prehľad spája súčasnú literatúru a odhaľuje, že spôsob pôrodu môže ovplyvniť epigenetické markery u novorodencov, predovšetkým prostredníctvom zmien globálnej metylácie DNA a génovo špecifických metylačných vzorcov.

Klíčová slova:

cisársky rez – metylácia DNA – epigenetika


Authors: Zuzana Turcsányiová ;  Petra Gašparová ;  Zuzana Ballová ;  Erik Dosedla
Authors place of work: Department of Gynaecology and Obstetrics, Faculty of Medicine, Pavol Jozef Safarik University in Košice, Hospital AGEL Košice-Šaca Inc., Slovak Republic
Published in the journal: Ceska Gynekol 2024; 89(4): 329-334
Category: Přehledová práce
doi: https://doi.org/10.48095/cccg2024329

Summary

Recent decades have seen a notable increase in cesarean section rates. Although lifesaving, cesarean delivery is associated with an elevated risk of adverse health outcomes in newborns, including respiratory diseases, atopic disorders, obesity, diabetes, and severe autoimmune conditions. The exact mechanisms underlying these associations remain elusive; however, epigenetic modifications have emerged as a plausible molecular basis linking perinatal factors with future disease susceptibility. This review summarizes current literature, revealing that the delivery method may influence epigenetic markers in neonates, primarily through alterations in global DNA methylation and gene-specific methylation patterns.

Keywords:

DNA methylation – Epigenetics – cesarean section

Introduction

In recent decades, the incidence of cesarean sections (C-sections) has surged globally, becoming the most frequent surgical intervention among women. According to a report by The Lancet, the global rate of C-sections increased from 12.2% in 2000 to approximately 21.1% by 2015 [1]. Notably, countries such as Brazil, Cyprus, and the Dominican Republic have reported C-section rates exceeding 50%, with more than 26 countries worldwide surpassing the 30% mark [2]. This upward trend can be attributed to a combination of anatomical and evolutionary changes, including a rise in cephalopelvic disproportion, genetic factors, and significant environmental shifts over the years. Improved living conditions and maternal nutrition have contributed to an increase in maternal body mass index (BMI) and the age at which women have their first child. These factors are associated with a higher prevalence of diabetes with diabetic fetopathy, fetal macrosomia, and maternal hypertensive disorders [3,4].

The escalating prevalence of C-sections has sparked considerable scientific interest in examining the procedure‘s implications for children‘s health and development. While C-sections can be lifesaving, they significantly alter the physiological processes inherent to spontaneous vaginal birth. Newborns delivered via C-section are exposed to a variety of hormonal, physical, bacterial, and medical interventions, including intrapartum antibiotics and uterotonics, which can subtly influence physiological outcomes [5]. A critical aspect of C-sections is the marked reduction in childbirth-related stress [6]. Elective C-sections, performed before labor onset, interrupt the natural release of catecholamines, potentially leading to immune system maladaptation [7]. Immediate consequences for the newborn may include altered immune reactivity, diminished inflammatory marker expression, and an elevated risk of developing hypersensitivity, skin atopy, asthma [8–10], and decreased intestinal microbiome diversity [11–14]. The long-term persistence of these risks is not well-understood [5]. Numerous epidemiological studies have identified an association between C-section delivery and an increased risk of autoimmune responses later in life, including type 1 diabetes [15,16], inflammatory bowel diseases, celiac disease [17], allergies [18], metabolic syndrome, obesity [19–23], arterial hypertension, and certain malignancies such as leukemia [24,25] and neuroblastoma [26,27] in childhood and adolescence.

The mechanisms by which delivery mode impacts the development of immunity and the incidence of immune-related diseases in children are not fully elucidated. Specifically, the reduction in childbirth stress associated with C-sections, which may result in immune system maladaptation, has been linked to epigenetic alterations in gene expression regulating white blood cells. Such alterations are referred to as epigenetic changes when they occur at the gene expression level. Epigenetic mechanisms, which include DNA methylation, histone modification, and the activity of non-coding RNA molecules, regulate gene expression without altering the DNA sequence, leading to changes in gene activity or function due to epimutations. Studies suggest that the mode of delivery may trigger epigenetic modifications that influence immunological processes in children during the postnatal period [28–34]. Among the various epigenetic control mechanisms, DNA methylation is the most extensively studied. Unlike true genetic mutations, which are generally random and irreversible, epigenetic changes are often reversible and modifiable. Nonetheless, epigenetic DNA methylation can remain stable throughout a cell‘s life and across cell divisions. DNA methylation and the epigenetic cellular memory associated with the mode of delivery could constitute a molecular mechanism for later development of immune-related diseases, particularly if DNA methylation occurs in progenitor cells [30]. Epigenetic programming is most active during the fetal period and extends from conception until the child reaches two years of age, making the first 1,000 days critical [35,36].

The epigenome‘s responsiveness to environmental factors, including the conditions of delivery, suggests that altered fetal or neonatal epigenetic modifications may influence susceptibility to diseases later in life [37–39]. Global DNA methylation pattern measurements serve as a practical approach for detecting different epigenetic effects in neonates. This review aims to provide a comprehensive overview of studies focusing on changes in DNA methylation in the newborns‘ blood, depending on the mode of delivery.

 

DNA methylation changes

The earliest documentation of a correlation between elective cesarean section and elevated DNA methylation levels at birth compared to vaginal delivery was introduced by Schlinzig et al. in 2009 [28]. This foundational study included 37 healthy newborns, comprising 21 spontaneous vaginal deliveries and 16 elective cesarean sections. By analyzing DNA extracted from white blood cells in umbilical cord blood immediately after birth and again during the third to fifth round of routine newborn screening, they discovered significantly higher global DNA methylation levels in the cesarean section group at birth. However, these levels stabilized in newborns delivered vaginally when assessed from birth to 3–5 days postnatally. Although the cesarean section group experienced a reduction in DNA methylation levels by days 3–5, making them comparable to vaginal delivery levels, the epigenetic adaptation observed post-cesarean did not achieve the physiological benchmarks observed in vaginal deliveries, indicating a potential deviation in epigenetic activity. The study, however, was limited by its small sample size [28].

Expanding on this work, Virani et al. (2012) [40] assessed global methylation in a larger cohort (408 births), exploring the association between delivery type and epigenetic alterations. This study differentiated between spontaneous vaginal, elective cesarean, and emergency cesarean deliveries post-labor onset. Using DNA isolated from cord blood, the study employed two global methylation measurement techniques – Luminometric Methylation Assay (LUMA) and LINE-1 methylation assay – to enhance result reliability. The findings indicated significantly lower DNA methylation levels in cesarean deliveries, both planned and total, compared to vaginal deliveries. However, these associations dissipated after adjusting for maternal age, smoking, and infant gender, suggesting that while delivery mode may influence health outcomes, global genomic methylation might not be the underlying mechanism. This study also noted limitations, including the lack of adjustment for critical perinatal and maternal factors potentially influencing fetal epigenetic modifications.

A Polish study by Słabuszewska-Jóźwiak (2020) [31] involved 111 pregnant women identifying notably lower DNA methylation levels in elective cesarean deliveries compared to vaginal and intrapartum cesarean deliveries. This study was unique in its examination of global DNA methylation levels in placental tissue, rather than in cord or peripheral infant blood, unveiling the impact of uterine contractions prior to cesarean delivery on DNA methylation levels [31,40] and demonstrating sexual dimorphism in placental global DNA methylation. As an ongoing pilot study, the outcomes of neonatal follow-up promise further insights.

Franz et al. (2014) [32] conducted a prospective pilot study with 41 neonates, comparing global methylation and methylation of 96 individual genes between spontaneous and elective cesarean deliveries. This investigation found no significant differences in global methylation based on delivery mode but identified specific genes with hypermethylation patterns. Notably, genes related to T cell activation and inflammatory responses exhibited lower methylation in vaginally born infants, suggesting enhanced gene activity [32]. Despite its strengths, including stringent inclusion criteria and a well-characterized cohort, the study‘s small sample size was a limitation.

In China, where cesarean delivery rates are among the highest globally [41], a study compared DNA methylation in cord blood following maternal-request cesarean deliveries without medical indications to spontaneous vaginal deliveries [33]. Analyzing 70 cases each, through both Illumina Infinium Human Methylation 450 K BeadChip and targeted bisulfite sequencing, the study identified 165 differentially methylated positions associated with immune system development. After adjusting for cell type proportions, significant differences in DNA methylation between groups were minimal, aligning with prior research findings [33].

A recent Turkish study found no significant differences in global DNA methylation between delivery modes [34]. However, it reported a significant increase in global DNA methylation levels associated with maternal age over 30 in both mothers and infants. Focusing on the PTEN gene, known for its role in cellular functions and epigenetic diseases [42–45], the study observed higher methylation rates in the cesarean delivery group, suggesting potential implications for disease susceptibility.

An observational study [30] examining the effect of delivery mode on neonatal hematopoietic stem cell epigenetics identified differential DNA methylation patterns that could influence lifelong disease susceptibility. The study high-lighted the modulation of genes related to immunoglobulin biosynthesis and metabolic regulation, suggesting that labor duration and the delivery mode significantly impact DNA methylation.

Further expanding on this research, Schlinzig et al. (2017) [29] analyzed immune deficiency markers in 6014 newborns, adjusting for perinatal and maternal factors. The study suggested that elective cesarean sections might affect the formation of new T- and B-lymphocytes, a hypothesis requiring further exploration for its immunological implications.

Lastly, experimental studies [45] on neonatal stress in rats have linked DNA methylation changes in glucocorticoid receptors to increased stress reactivity, underscoring the need for continued investigation into the epigenetic impacts of birth mode on health outcomes.

 

Discussion

The correlation between the increasing prevalence of cesarean deliveries and the incidence of immune-related disorders is an area of growing concern and investigation. The hypothesis that variations in DNA methylation between individuals born via cesarean section versus those born vaginally may explain the potential long-term health effects of cesarean sections is particularly compelling. Aberrant DNA methylation patterns are linked to a range of immune deficiencies and autoimmune diseases, highlighting the importance of understanding the epigenetic consequences of birth modes [46].

Although several studies have explored the relationship between DNA methylation changes and delivery methods, inconsistencies in their findings – attributable to diverse research methodologies – offer a complex but intriguing picture. Current literature, after adjusting for confounding variables, generally shows no significant differences in global DNA methylation between cesarean and vaginal delivery groups [28,32,34,40]. However, Almgren et al.‘s analysis of CD34+ hematopoietic stem cells stands out, revealing a notable impact of delivery mode on global DNA methylation patterns, with cesarean-delivered newborns exhibiting higher levels of DNA methylation compared to vaginally delivered infants [30]. This discrepancy highlights the importance of cellular context in epigenetic studies, as Almgren et al.‘s focus on CD34+ cells may account for their distinct findings.

Moreover, global methylation assessments do not preclude variations at the single-gene level. For instance, Franz et al. [32] detected hypermethylation in specific genes – FOXP3, CD7, ELA2, and IRF1 – regardless of delivery mode, with notable differences in ELA2 and IRF1 methylation between cesarean and vaginal deliveries. This suggests that vaginal birth may activate these genes more effectively. Such genetic alterations have implications for various diseases [47–49], underscoring the necessity of examining methylation at both global and gene-specific levels.

In gene-targeted analyses, disparities in methylation patterns have been linked to immune system development and potential autoimmune disease risks. For example, Chen et al. [34] identified genes with significant implications for immune response development in newborns. Furthermore, Uslu Yuvaci et al. [34] found higher PTEN gene methylation rates in the cesarean delivery group, correlating with the concept of the “DNA methylation clock,“ which may be influenced by maternal age [50,51].

Almgren et al. also reported methylation changes related to glucose metabolism regulation, suggesting possible links to the increased risk of obesity and diabetes in individuals delivered by cesarean section [52–54]. Additionally, Schlinzig‘s work suggests that cesarean delivery may affect the formation of T- and B-lymphocytes, potentially impacting future immunological functions [29].

In summary, while the mode of delivery is associated with later health out--comes, global genomic methylation might not be the sole mechanism involved. The complexity of epigenetic modifications, including those influenced by perinatal and maternal factors, highlights the need for a nuanced understanding of how delivery methods impact epigenetic programming and subsequent health risks.

 

Conclusion

The synthesis of findings across diverse studies highlights the complexity of comparing outcomes due to varied methodologies employed in assessing DNA methylation. A critical limitation across the board is the absence of longitudinal epigenetic assessments post-delivery. Since methylation patterns are dynamic over time, longitudinal data could significantly enrich the field of epigenetic epidemiology by providing insights into the temporal nature of these changes. Consequently, there is an imperative need for large-scale studies that monitor methylation profiles at various life stages to ascertain whether the influence of delivery mode on the epigenome emerges or persists later in life.

The existing body of research opens promising avenues for future investigations into the correlations between DNA methylation variations and health out- -comes across the lifespan, particularly during adolescence and adulthood. It is crucial for subsequent studies to meticulously control for potential confounders, acknowledging that numerous environmental factors – ranging from tobacco exposure [55–57] and dietary habits to maternal stress [58] and pre-pregnancy obesity [59] – can influence both global and gene-specific methylation patterns.

Future research should pivot towards gene-specific analyses, particularly focusing on genes implicated in immune-related diseases. Exploring diverse gene panels may uncover additional genes that undergo aberrant methylation in newborns delivered via cesarean section as compared to vaginal delivery. Comprehensive evaluations of these genes in large cohorts are essential to determine if differential methylation levels are associated with distinct long-term health outcomes post-cesarean section. Continuous follow-up is necessary to conclusively determine whether cesarean delivery impacts DNA methylation in a manner that predisposes to disease later in life, including during childhood, adolescence, and adulthood.


Zdroje

1. Boerma T, Ronsmans C, Melesse DY et al. Global epidemiology of use of and disparities in cesarean sections. Lancet 2018; 392 (10155): 1341–1348. doi: 10.1016/S0140-6736 (18) 31928-7.

2. Betrán AP, Ye J, Moller AB et al. The increasing trend in cesarean section rates: global, regional, and national estimates: 1990–2014. PLoS One 2016; 11 (2): e0148343. doi: 10.1371/journal.pone.0148343.

3. Ghahiri A, Khosravi M. Maternal and neonatal morbidity and mortality rate in cesarean section and vaginal delivery. Adv Biomed Res 2015; 4: 193. doi: 10.4103/2277-9175.166154.

4. Liu S, Liston RM, Joseph KS et al. Maternal Health Study Group of the Canadian Perinatal Surveillance System. Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term. CMAJ 2007; 176 (4): 455–460. doi: 10.1503/cmaj.060870.

5. Sandall J, Tribe RM, Avery L et al. Short- -term and long-term effects of cesarean section on the health of women and children. Lancet 2018; 392 (10155): 1349–1357. doi: 10.1016/S0140-6736 (18) 31930-5.

6. Kenkel W. Birth signaling hormones and the developmental consequences of cesarean delivery. J Neuroendocrinol 2021; 33 (1): e12912. doi: 10.1111/jne.12912.

7. Tribe RM, Taylor PD, Kelly NM et al. Parturition and the perinatal period: can mode of delivery impact on the future health of the neonate? J Physiol 2018; 596 (23): 5709–5722. doi: 10.1113/JP275429.

8. Black M, Bhattacharya S, Philip S et al. Planned repeat cesarean section at term and adverse childhood health outcomes: a record-linkage study. PLoS Med 2016; 13 (3): e1001973. doi: 10.1371/journal.pmed.1001973.

9. Baumfeld Y, Walfisch A, Wainstock T et al. Elective cesarean delivery at term and the long-term risk for respiratory morbidity for the offspring. Eur J Pediatr 2018; 177 (11): 1653–1659. doi: 10.1007/s00431-018-3225-8.

10. Darabi B, Rahmati S, HafeziAhmadi MR et al. The association between cesarean section and childhood asthma: an updated systematic review and meta-analysis. Allergy Asthma Clin Immunol 2019; 15: 62. doi: 10.1186/s13223- 019-0367-9.

11. Shao Y, Forster SC, Tsaliki E et al. Stunted microbiota and opportunistic pathogen colonization in cesarean-section birth. Nature 2019; 574 (7776): 117–121. doi: 10.1038/s41 586-019-1560-1.

12. Magne F, Puchi Silva A, Carvajal B et al. The elevated rate of cesarean section and its contribution to non-communicable chronic diseases in Latin America: the growing involvement of the microbiota. Front Pediatr 2017; 5: 192. doi: 10.3389/fped.2017.00192.

13. Tamburini S, Shen N, Wu HC et al. The microbiome in early life: implications for health outcomes. Nat Med 2016; 22 (7): 713–722. doi: 10.1038/nm.4142.

14. Gensollen T, Iyer SS, Kasper DL et al. How colonization by microbiota in early life shapes the immune system. Science 2016; 352 (6285): 539–544. doi: 10.1126/science.aad9378.

15. Tanoey J, Gulati A, Patterson C et al. Risk of type 1 diabetes in the offspring born through elective or non-elective cesarean section in comparison to vaginal delivery: a meta-analysis of observational studies. Curr Diab Rep 2019; 19 (11): 124. doi: 10.1007/s11892-019- 1253-z.

16. Bonifacio E, Warncke K, Winkler C et al. Cesarean section and interferon-induced helicase gene polymorphisms combine to increase childhood type 1 diabetes risk. Diabetes 2011; 60 (12): 3300–3306. doi: 10.2337/db11-0729.

17. Andersen V, Möller S, Jensen PB et al. Cesarean section delivery and risk of chronic inflammatory diseases (inflammatory bowel disease, rheumatoid arthritis, coeliac disease, and diabetes mellitus): a population-based registry study of 2,699,479 births in Denmark during 1973–2016. Clin Epidemiol 2020; 12: 287–293. doi: 10.2147/CLEP.S229056.

18. Pistiner M, Gold DR, Abdulkerim H et al. Birth by cesarean section, allergic rhinitis, and allergic sensitization among children with a parental history of atopy. J Allergy Clin Immunol 2008; 122 (2): 274–279. doi: 10.1016/j.jaci.2008. 05.007.

19. Kuhle S, Tong OS, Woolcott CG. Association between cesarean section and childhood obesity: a systematic review and meta-analysis. Obes Rev 2015; 16 (4): 295–303. doi: 10.1111/obr.12267.

20. Chojnacki M, Holscher H, Balbinot A et al. Relations between mode of birth delivery and timing of developmental milestones and adiposity in preadolescence: a retrospective study. Early Hum Dev 2019; 129: 52–59. doi: 10.1016/ j.earlhumdev.2018.12.021.

21. Zhou Y, Zhang Y, Sun Y et al. Association of cesarean birth with body mass index trajectories in adolescence. Int J Environ Res Public Health 2020; 17 (6): 2003. doi: 10.3390/ijerph17062 003.

22. Mueller N, Zhang M, Rifas-Shiman S et al. Mode of delivery, type of labor, and measures of adiposity from childhood to teenage: project Viva. J Obes 2021; 45 (1): 36–44. doi: 10.1038/s41366-020-00709-x.

23. Sitarik A, Havstad S, Johnson C et al. Association between cesarean delivery types and obesity in preadolescence. Int J Obes 2020; 44 (10): 2023–2034. doi: 10.1038/s41366-020-00 663-8.

24. Marcotte EL, Thomopoulos TP, Infante-Rivard C et al. Cesarean delivery and risk of childhood leukemia: a pooled analysis from the Childhood Leukemia International Consortium (CLIC). Lancet Haematol 2016; 3 (4): e176–e185. doi: 10.1016/S2352-3026 (16) 00002-8.

25. Jiang LL, Gao YY, He WB et al. Cesarean section and risk of childhood leukemia: a systematic review and meta-analysis. World J Pediatr 2020; 16 (5): 471–479. doi: 10.1007/s12519- 020-00338-4.

26. Keag OE, Norman JE, Stock SJ. Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: systematic review and meta-analysis. PLoS Med 2018; 15 (1): e1002494. doi: 10.1371/journal.pmed.1002494.

27. Sevelsted A, Stokholm J, Bønnelykke K et al. Cesarean section and chronic immune disorders. Pediatrics 2015; 135 (1): e92–e98. doi: 10.1542/peds.2014-0596.

28. Schlinzig T, Johansson S, Gunnar A et al. Epigenetic modulation at birth – altered DNA-methylation in white blood cells after cesarean section. Acta Paediatr 2009; 98 (7): 1096–1099. doi: 10.1111/j.1651-2227.2009.01371.x.

29. Schlinzig T, Johansson S, Stephansson O et al. Surge of immune cell formation at birth differs by mode of delivery and infant characteristics – a population-based cohort study. PLoS One 2017; 12 (9): e0184748. doi: 10.1371/journal.pone.0184748.

30. Almgren M, Schlinzig T, Gomez-Cabrero D et al. Cesarean delivery and hematopoietic stem cell epigenetics in the newborn infant: implications for future health? Am J Obstet Gynecol 2014; 211 (5): 502.e1–502.e8. doi: 10.1016/ j.ajog.2014.05.014.

31. Słabuszewska-Jóźwiak A, Włodarczyk M, Ciebiera M et al. Placental DNA methylation in cesarean sections – a pilot study. Arch Med Sci 2020. doi: 10.5114/aoms.2020.95422.

32. Franz MB, Poterauer M, Elhenicky M et al. Global and single gene DNA methylation in umbilical cord blood cells after elective cesarean: a pilot study. Eur J Obstet Gynecol Reprod Biol 2014; 179: 121–124. doi: 10.1016/ j.ejogrb.2014.05.038.

33. Chen Q, Ming Y, Gan Y et al. The impact of cesarean delivery on infant DNA methylation. BMC Pregnancy Childbirth 2021; 21 (1): 265. doi: 10.1186/s12884-021-03748-y.

34. Uslu Yuvacı H, Kalaycı A, Aslan MM et al. Evaluation of the effect of delivery mode on methylation changes in the global DNA and the PTEN gene. J Clin Obstet Gynecol 2023; 33 (2): 111–117. doi: 10.5336/jcog.2022- 94979.

35. Boersma GJ, Bale TL, Casanello P et al. Long--term impact of early life events on physiology and behavior. J Neuroendocrinol 2014; 26 (9): 587–602. doi: 10.1111/jne.12153.

36. 1,000 days non-profit organization. 2019 [online]. Available from: https: //thousanddays.org.

37. Bernal AJ, Jirtle RL. Epigenomic disruption: the effects of early developmental exposures. Birth Defects Res A Clin Mol Teratol 2010; 88 (10): 938–944. doi: 10.1002/bdra.20685.

38. Dolinoy DC, Weidman JR, Jirtle RL. Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 2007; 23 (3): 297–307. doi: 10.1016/j.reprotox.2006.08.012.

39. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 8 (4): 253–262. doi: 10.1038/nrg 2045.

40. Virani S, Dolinoy DC, Halubai S et al. Delivery type not associated with global methylation at birth. Clin Epigenetics 2012; 4 (8): 8. doi: 10.1186/1868-7083-4-8.

41. Mi J, Liu F. Rate of cesarean section is alarming in China. Lancet 2014; 383 (9927): 1463–1464. doi: 10.1016/S0140-6736 (14) 60716-9.

42. Radford EJ, Isganaitis E, Jimenez-Chillaron J et al. An unbiased assessment of the role of imprinted genes in an intergenerational model of developmental programming. PLoS Genet 2012; 8 (4): e1002605. doi: 10.1371/journal.pgen.1002605.

43. Li Y, Wang XY, Wu T et al. PTEN is involved in modulation of vasculogenesis in early chick embryos. Biol Open 2013; 2 (6): 587–595. doi: 10.1242/bio.20133988.

44. Gupta A, Anjomani-Virmouni S, Koundouros N et al. PARK2 depletion connects energy and oxidative stress to PI3K/Akt activation via PTEN S-nitrosylation. Mol Cell 2017; 65 (6): 999.e7–1013.e7. doi: 10.1016/j.molcel.2017.02.019.

45. Weaver IC, Cervoni N, Champagne FA et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7 (8): 847–854. doi: 10.1038/nn1276.

46. Suarez-Alvarez B, Rodriguez RM, Fraga MF et al. DNA methylation: a promising landscape for immune system-related diseases. Trends Genet 2012; 28 (10): 506–514. doi: 10.1016/j.tig.2012.06.005.

47. Kim J, Bhattacharjee R, Khalyfa A et al. DNA methylation in inflammatory genes among children with obstructive sleep apnea. Am J Respir Crit Care Med 2012; 185 (3): 330–338. doi: 10.1164/rccm.201106-1026OC.

48. Röhrs S, Scherr M, Romani J et al. CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulation. J Hematol Oncol 2010; 3: 15. doi: 10.1186/1756-8722-3-15.

49. Yong AS, Szydlo RM, Goldman JM et al. Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML. Blood 2006; 107 (1): 205–212. doi: 10.1182/blood-2005-05- 2155.

50. López-Otín C, Blasco MA, Partridge L et al. The hallmarks of aging. Cell 2013; 153 (6): 1194–1217. doi: 10.1016/j.cell.2013.05.039.

51. Field AE, Robertson NA, Wang T et al. DNA methylation clocks in aging: categories, causes, and consequences. Mol Cell 2018; 71 (6): 882–895. doi: 10.1016/j.molcel.2018.08.008.

52. Chavarro JE, Martin-Calvo N, Yuan C et al. Association of birth by cesarean delivery with obesity and type 2 diabetes among adult women. JAMA Netw Open 2020; 3 (4): e202605. doi: 10.1001/jamanetworkopen.2020.2605.

53. Dal‘Maso E, Rodrigues PR, Ferreira G et al. Cesarean birth and risk of obesity from birth to adolescence: a cohort study. Birth 2022; 49 (4): 774–782. doi: 10.1111/birt.12644.

54. Jensen ET, Bertoni AG, Crago OL et al. Cesarean delivery and insulin sensitivity in the older adult: the microbiome and insulin longitudinal evaluation study. J Endocr Soc 2022; 6 (7): bvac072. doi: 10.1210/jendso/ bvac072.

55. Morales E, Vilahur N, Salas LA et al. Genome-wide DNA methylation study in human placenta identifies novel loci associated with maternal smoking during pregnancy. Int J Epidemiol 2016; 45 (5): 1644–1655. doi: 10.1093/ije/ dyw196.

56. Fa S, Larsen TV, Bilde K et al. Assessment of global DNA methylation in the first trimester fetal tissues exposed to maternal cigarette smoking. Clin Epigenetics 2016; 8: 128. doi: 10.1186/s13148-016-0296-0.

57. Crute C, Liao Y, Son E et al. Validation of differential DNA methylation in newborns exposed to tobacco smoke during gestation using bisulfite pyrosequencing. MicroPubl Biol 2022; 2022: 10. doi: 10.17912/micropub.biology.000509.

58. Brunst KJ, Tignor N, Just A et al. Cumulative lifetime maternal stress and epigenome-wide placental DNA methylation in the PRISM cohort. Epigenetics 2018; 13 (6): 665–681. doi: 10.1080/15592294.2018.1497387.

59. Binder NK, Beard SA, Kaitu’u-Lino TJ et al. Paternal obesity in a rodent model affects placental gene expression in a sex-specific manner. Reproduction 2015; 149 (5): 435–444. doi: 10.1530/REP-14-0676.

ORCID authors
Z. Turcsányiová 0000-0002-6376-0790
P. Gašparová 0000-0002-6354-6911
Z. Ballová 0000-0002-0605-948X
E. Dosedla 0000-0001-8319-9008
Submitted/Doručené: 18. 10. 2023
Accepted/Prijaté: 20. 10. 2023
Assoc. Prof. Erik Dosedla, MD, PhD, MBA
Department of Gynaecology and Obstetrics
Faculty of Medicine
Pavol Jozef Safarik University
Hospital AGEL Košice-Šaca Inc.
Lúčna 57
040 15 Košice-Šaca
Slovak Republic
erik.dosedla@nke.agel.sk
Štítky
Dětská gynekologie Gynekologie a porodnictví Reprodukční medicína

Článek vyšel v časopise

Česká gynekologie

Číslo 4

2024 Číslo 4

Nejčtenější v tomto čísle
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#